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Commentary on “Chronic Idiopathic Urticaria in
Taiwan: A Clinical Study of Demographics,
Aggravating Factors, Laboratory Findings, Serum
Autoreactivity and Treatment Response”
Tsen-Fang Tsai*
In this issue, Lee et al performed a prospective
cross-sectional, single-center study which included
62 chronic idiopathic urticaria (CIU) patients in
Taiwan.1 A higher prevalence of atopy, especially
allergic rhinitis, occurred in CIU patients than in
general adult population in this study. The authors
did not find any associations between the severi-
ties of CIU but patients with atopy were associated
with poorer therapeutic response of second-
generation antihistamine with standard dose.
The role of atopy in CIU has been controversial.
Despite the higher prevalence of atopy in CIU in
this paper, a selection bias may be present be-
cause patients with poor response to standard dose
of anti-histamine may be overrepresented in a
tertiary referral hospital.
Urticaria has been considered as a condition
that the local dermal edema occurs because of the
release of histamine from mast cells. However,
recent studies have found the roles of other va-
soactive mediators, such as prostaglandin, kinin,
and interleukin-31 in the pathogenesis of CIU.2
The involvement of cytokines other than histamine
provides an explanation for the ineffectiveness of
antihistamine and the needs of immunomodu-
latory therapy in selected cases of CIU.
Chronic urticaria is an enigmatic condition
and search for a specific cause is often futile despite
an extensive work-up. Food allergy is the most
frequently sought after cause for chronic urticaria
for the patients, and hence tests for specific IgE are
often performed. However, only rarely can food
be incriminated as the cause for chronic urticaria.
Instead, there is emergent evidence to suggest an
autoimmune basis in up to 60% of patients with
CIU.3 Severe itching, extensive disease, more sys-
temic symptoms, resistant to antihistamine treat-
ment and need of immunosuppressant therapy are
key clinical features described for this group of
patients.4
Autologous serum skin test (ASST) is a non-
specific screening test which evaluates the pres-
ence of serum histamine-releasing factors and
has been used as a surrogate test for the detection
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of anti-FceRI and anti-IgE autoantibodies.5 The
basophil histamine release assay, however, remains
the gold standard investigation to detect these
functional autoantibodies in vitro, and this assay
may be negative in ASST positive subjects. Besides,
positive ASST has also been detected in patients
without CIU. Thus, autoreactive urticaria may be
a more appropriate diagnosis than autoimmune
urticaria for patients with positive ASST.6,7 There is
also a need of controlled studies to justify the
early use of high dose of antihistamine or immu-
nomodulatory therapy in patients with positive
ASST. Although the current international guide-
lines for urticaria recognize the role of ASST in
CIU, the stepwise therapeutic recommendation
does not differentiate between the ASST positive
and negative groups.
In 61.3% of CIU patients in this study, there
was at least one serum specific IgE antibody and
as expected, mite allergy was the most common
allergen.1 However, the clinical features and ther-
apeutic response were not statistically different
between the two groups. Likewise, in the revised
international consensus on urticaria, differential
blood count and ESR or C-reactive protein are the
only routine diagnostic tests suggested for CIU.8
Diagnostic workups of CIU may be extensive, and
hence expensive. An individualized approach 
is suggested for the non-routine tests. Careful 
interpretation of the result is imperative and a
thorough history taking remains most crucial in
finding the cause of CIU.
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